Ajanta Pharma Share Price
3488.80-32.30 (-0.92%)
+36.41% past 1 Year
News
Ajanta Pharma Q1 EBITDA rises year-on-year; margin moderates slightly
Equity
AJANTPHARM
Ajanta Pharma reports Q1 revenue growth to Rs 1,630 crores
Equity
AJANTPHARM
Ajanta Pharma Q1 consolidated net profit jumps sharply on strong YoY growth
Equity
AJANTPHARM
Ajanta Pharma receives USFDA inspection report for Paithan facility
Equity
AJANTPHARM
Ajanta Pharma informs about AGM
Equity
AJANTPHARM
Ajanta Pharma trades higher on the bourses
Equity
AJANTPHARM
Ajanta Pharma’s promoter sells stake worth Rs 1023.96 crore
Equity
AJANTPHARM
Ajanta Pharma informs about disclosure
Equity
AJANTPHARM
Ajanta Pharma informs about SAST updates
Equity
AJANTPHARM
Ajanta Pharma sees Rs 400 crore NSE block trade in pre open session
Equity
AJANTPHARM
Ajanta Pharma informs about disclosure
Equity
AJANTPHARM
Ajanta Pharma informs about secretarial compliance report
Equity
AJANTPHARM
Ajanta Pharma Forecasts 16-18% Revenue Growth for FY27, Targets 27% EBITDA Margin Amid Investments.
Equity
AJANTPHARM
Jefferies Maintains Buy on Ajanta Pharma with Rs 3550 Target on Strong Q4 Growth in Africa and US.
Equity
AJANTPHARM
Ajanta Pharma - Quaterly Results
Equity
AJANTPHARM
Ajanta Pharma Reports Q4 Revenue Growth to Rs 1422 Crores, Up from Rs 1170 Crores YoY
Equity
AJANTPHARM
Ajanta Pharma Q4 EBITDA Growth Tempered by Margin Compression
Equity
AJANTPHARM
Ajanta Pharma Q4 Consolidated Net Profit Rises 20% YoY to Rs 270 Crores
Equity
AJANTPHARM
Ajanta Pharma reports Profit after tax of 197.28 Crores, in the March 2026 quarter
Equity
AJANTPHARM
USFDA concludes inspection at Ajanta Pharma’s Paithan manufacturing facility
Equity
AJANTPHARM